labquiet_amy said:For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.
Agreed on the substance. I would put less weight on the timescale, because two months of anything is not enough to distinguish a trend from a wobble.
labquiet_amy said:For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.
Saving this. It is the first explanation that did not require me to already understand it. Adding it to my notes with a link back to this thread.
From the other side of the consultation, briefly. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.
I would rather be corrected than agreed with, if it comes to it.
PeptideDetective — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsDr.PainCLE said:There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.
This matches mine closely enough to be worth saying so out loud.
Closing the loop on my own question.
Update — my curve sits below the published mean and the explanation is that the trial arm had support I do not have. That was reassuring rather than otherwise.